Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non-Small-Cell Lung Cancer: The NVALT-4 Study.

Autor: Groen HJ, Sietsma H, Vincent A, Hochstenbag MM, van Putten JW, van den Berg A, Dalesio O, Biesma B, Smit HJ, Termeer A, Hiltermann TJ, van den Borne BE, Schramel FM

Publikováno v: Journal of Clinical Oncology; 11/10/2011, Vol. 29 Issue 32, p4320-4326, 7p

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.

Autor: Hendriks LE; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. Electronic address: Lizza.hendriks@mumc.nl., Derks JL; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. Electronic address: j.derks@maastrichtuniversity.nl., Postmus PE; Department of Pulmonary Diseases, Clatterbridge Cancer Centre, Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, UK. Electronic address: pepostmus@gmail.com., Damhuis RA; Department of Registry and Research, Comprehensive Cancer Centre the Netherlands, Rotterdam, The Netherlands. Electronic address: R.Damhuis@iknl.nl., Houben RM; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. Electronic address: Ruud.houben@maastro.nl., Troost EG; Department of Radiation Oncology, University Hospital and Medical Faculty Carl Gustav Carus of TU Dresden, Fetscherstr. 74, 01307 Dresden, Germany. Electronic address: Esther.Troost@uniklinikum-dresden.de., Hochstenbag MM; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. Electronic address: m.hochstenbag@mumc.nl., Smit EF; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: E.smit@nki.nl., Dingemans AM; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. Electronic address: a.dingemans@mumc.nl.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Nov; Vol. 51 (17), pp. 2534-44. Date of Electronic Publication: 2015 Aug 28.

MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?

Autor: Hochstenbag MM; Department of Respiratory Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands., Twijnstra A, Hofman P, Wouters EF, ten Velde GP

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2003 Nov; Vol. 42 (2), pp. 189-93.

In-111 octreotide imaging in staging of small cell lung cancer.

Autor: Hochstenbag MM; Department of Pulmonology, University Hospital Maastricht, The Netherlands., Heidendal GA, Wouters EF, ten Velde GP

Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 1997 Dec; Vol. 22 (12), pp. 811-6.

Detection of bone marrow metastases in small cell lung cancer. Comparison of magnetic resonance imaging with standard methods.

Autor: Hochstenbag MM; Department of Pulmonology, University Hospital, Maastricht, Netherlands., Snoep G, Cobben NA, Schols AM, Thunnissen FB, Wouters EF, ten Velde GP

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 1996 May; Vol. 32A (5), pp. 779-82.